Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases

BioEssays

Volumn 34, Issue 12, 2012, Pages 1050-1059

  Klein, Sabra L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hepatitis; Herpes simplex virus; HIV; Influenza; Sex difference

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CYTOKINE; ESTRADIOL; HEPATITIS B VACCINE; HERPES SIMPLEX VACCINE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLUENZA VACCINE; INTERFERON REGULATORY FACTOR 1; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OSELTAMIVIR; PEGINTERFERON ALPHA; PROGESTERONE; RIBAVIRIN; TESTOSTERONE; VIRUS VACCINE; ZANAMIVIR; ZIDOVUDINE;

ADAPTIVE IMMUNITY; ANTIVIRAL THERAPY; ARTICLE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DENGUE; DRUG EFFICACY; DRUG ERUPTION; EPSTEIN BARR VIRUS INFECTION; GASTROINTESTINAL DISEASE; GENDER; HANTAVIRUS INFECTION; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLUENZA; INNATE IMMUNITY; LACTIC ACIDOSIS; MEASLES; METABOLIC DISORDER; MONOCYTE; NONHUMAN; PATIENT COMPLIANCE; SEASONAL INFLUENZA; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; WEST NILE FEVER;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODY FORMATION; ANTIVIRAL AGENTS; FEMALE; GENES, MHC CLASS II; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; MALE; SEX CHARACTERISTICS; SEX FACTORS; TREATMENT OUTCOME; VACCINATION; VIRAL LOAD; VIRAL VACCINES; VIRUS DISEASES;

SIMPLEXVIRUS;

EID: 84869105969     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200099     Document Type: Article

References (119)

1. Meier A, Chang JJ, Chan ES, Pollard RB, et al. 2009. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15: 955-9.
2. Robinson DP, Lorenzo ME, Jian W, Klein SL. 2011. Elevated 17beta-estradiol protects females from influenza a virus pathogenesis by suppressing inflammatory responses. PLoS Pathog 7: e1002149.
3. Berghofer B, Frommer T, Haley G, Fink L, et al. 2006. TLR7 ligands induce higher IFN-alpha production in females. J Immunol 177: 2088-96.
4. Marriott I, Huet-Hudson YM. 2006. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 34: 177-92.
5. Hannah MF, Bajic VB, Klein SL. 2008. Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats. Brain Behav Immun 22: 503-16.
6. Klein SL, Jedlicka A, Pekosz A. 2010. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10: 338-49.
7. Boissier J, Chlichlia K, Digon Y, Ruppel A, et al. 2003. Preliminary study on sex-related inflammatory reactions in mice infected with Schistosoma mansoni. Parasitol Res 91: 144-50.
8. Xia HJ, Zhang GH, Wang RR, Zheng YT. 2009. The influence of age and sex on the cell counts of peripheral blood leukocyte subpopulations in Chinese rhesus macaques. Cell Mol Immunol 6: 433-40.
9. Melgert BN, Oriss TB, Qi Z, Dixon-McCarthy B, et al. 2010. Macrophages: regulators of sex differences in asthma? Am J Respir Cell Mol Biol 42: 595-603.
10. Butterworth M, McClellan B, Allansmith M. 1967. Influence of sex in immunoglobulin levels. Nature 214: 1224-5.
11. Klein SL, Huber S. 2010. Sex differences in susceptibility to viral infection. In Klein SL, Roberts CW, eds; Sex Hormones and Immunity to Infection. Berlin: Springer-Verlag. p. 93-122.
12. Cook IF. 2008. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 26: 3551-5.
13. Wikby A, Mansson IA, Johansson B, Strindhall J, et al. 2008. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 9: 299-308.
14. Villacres MC, Longmate J, Auge C, Diamond DJ. 2004. Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. Hum Immunol 65: 476-85.
15. Amadori A, Zamarchi R, De Silvestro G, Forza G, et al. 1995. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1: 1279-83.
16. Das BR, Bhanushali AA, Khadapkar R, Jeswani KD, et al. 2008. Reference ranges for lymphocyte subsets in adults from western India: influence of sex, age and method of enumeration. Indian J Med Sci 62: 397-406.
17. Roberts CW, Walker W, Alexander J. 2001. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 14: 476-88.
18. Araneo BA, Dowell T, Diegel M, Daynes RA. 1991. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 78: 688-99.
19. Barrat F, Lesourd B, Boulouis HJ, Thibault D, et al. 1997. Sex and parity modulate cytokine production during murine ageing. Clin Exp Immunol 109: 562-8.
20. Pinzan CF, Ruas LP, Casabona-Fortunato AS, Carvalho FC, et al. 2010. Immunological basis for the gender differences in murine Paracoccidioides brasiliensis infection. PLoS ONE 5: e10757.
21. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, et al. 2007. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178: 6710-4.
22. Hewagama A, Patel D, Yarlagadda S, Strickland FM, et al. 2009. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun 10: 509-16.
23. Kovats S, Carreras E, Agrawal H. 2010. Sex steroid receptors in immune cells. In Klein SL, Roberts CW, eds; Sex Hormones and Immunity to Infection. Berlin: Springer-Verlag. p. 53-92.
24. Arnold AP, Chen X. 2009. What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol 30: 1-9.
25. Stamova B, Tian Y, Jickling G, Bushnell C, et al. 2011. The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke 43: 326-34.
26. Pinheiro I, Dejager L, Libert C. 2011. X-chromosome-located microRNAs in immunity: might they explain male/female differences? BioEssays 33: 791-802.
27. Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, et al. 2008. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 205: 1099-108.
28. Robinson DP, Huber SA, Moussawi M, Roberts B, et al. 2011. Sex chromosome complement contributes to sex differences in Coxsackievirus B3 but not Influenza A virus pathogenesis. Biol Sex Differ 2: 8.
29. Poland GA, Ovsyannikova IG, Jacobson RM. 2008. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 8: 1659-67.
30. Gordeeva LA, Shabaldin AV, Semenova EM, Glushkov AN. 2006. Influence of genetic and phenotypical factors on the efficiency of the vaccination of young children against diphtheria and measles. Zh Mikrobiol Epidemiol Immunobiol 2: 42-6.
31. Siddiqui RA, Sauermann U, Altmuller J, Fritzer E, et al. 2009. X chromosomal variation is associated with slow progression to AIDS in HIV-1-infected women. Am J Hum Genet 85: 228-39.
32. Napravnik S, Poole C, Thomas JC, Eron JJ, Jr. 2002. Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr 31: 11-9.
33. Meditz AL, MaWhinney S, Allshouse A, Feser W, et al. 2011. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis 203: 442-51.
34. Hel Z, Stringer E, Mestecky J. 2010. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev 31: 79-97.
35. Grinspoon S. 2005. Androgen deficiency and HIV infection. Clin Infect Dis 41: 1804-5.
36. Teichmann J, Schmidt A, Lange U, Stracke H, et al. 2003. Longitudinal evaluation of serum estradiol and estrone in male patients infected with the human immunodeficiency virus. Eur J Med Res 8: 77-80.
37. Katagiri D, Hayashi H, Victoriano AF, Okamoto T, et al. 2006. Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1). Int Immunopharmacol 6: 170-81.
38. Gebo KA, Fleishman JA, Conviser R, Reilly ED, et al. 2005. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 38: 96-103.
39. Ofotokun I. 2005. Sex differences in the pharmacologic effects of antiretroviral drugs: potential roles of drug transporters and phase 1 and 2 metabolizing enzymes. Top HIV Med 13: 79-83.
40. Ofotokun I, Pomeroy C. 2003. Sex differences in adverse reactions to antiretroviral drugs. Top HIV Med 11: 55-9.
41. Currier JS, Spino C, Grimes J, Wofsy CB, et al. 2000. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr 24: 316-24.
42. Bersoff-Matcha SJ, Miller WC, Aberg JA, van Der Horst C, et al. 2001. Sex differences in nevirapine rash. Clin Infect Dis 32: 124-9.
43. Anderson PL, Kakuda TN, Kawle S, Fletcher CV. 2003. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals. AIDS 17: 2159-68.
44. Moore AL, Mocroft A, Madge S, Devereux H, et al. 2001. Gender differences in virologic response to treatment in an HIV-positive population: a cohort study. J Acquir Immune Defic Syndr 26: 159-63.
45. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-20.
46. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-93.
47. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, et al. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 347: 1652-61.
48. Wald A. 2004. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 11: 130A- 7A.
49. Cherpes TL, Melan MA, Kant JA, Cosentino LA, et al. 2005. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 40: 1422-8.
50. MacDonald EM, Savoy A, Gillgrass A, Fernandez S, et al. 2007. Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol Reprod 77: 1049-59.
51. Gallichan WS, Rosenthal KL. 1996. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 224: 487-97.
52. Gillgrass AE, Fernandez SA, Rosenthal KL, Kaushic C. 2005. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J Virol 79: 3107-16.
53. Han X, Lundberg P, Tanamachi B, Openshaw H, et al. 2001. Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice. J Virol 75: 3048-52.
54. Burgos JS, Ramirez C, Sastre I, Alfaro JM, et al. 2005. Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender. J Virol 79: 1605-12.
55. Geurs TL, Hill EB, Lippold DM, French AR. 2012. Sex differences in murine susceptibility to systemic viral infections. J Autoimmun 38: J245-53.
56. Stephenson J. 2000. Genital herpes vaccine shows limited promise. JAMA 284: 1913-4.
57. Gillgrass AE, Tang VA, Towarnicki KM, Rosenthal KL, et al. 2005. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J Virol 79: 3117-26.
58. Gillgrass A, Chege D, Bhavanam S, Kaushic C. 2010. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge. Am J Reprod Immunol 63: 299-309.
59. Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, et al. 1983. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis 147: 336-40.
60. Theng TS, Chan RK. 2004. Genital herpes in a sexually-transmitted infection clinic in Singapore: a 1-year retrospective study. Ann Acad Med Singapore 33: 200-3.
61. Tsay PK, Tai DI, Chen YM, Yu CP, et al. 2009. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J 32: 155-64.
62. Chen CJ, Yang HI, Su J, Jen CL, et al. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
63. El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-76.
64. Wang SH, Yeh SH, Lin WH, Wang HY, et al. 2009. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50: 1392-402.
65. Yu MW, Cheng SW, Lin MW, Yang SY, et al. 2000. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 92: 2023-8.
66. Ma WL, Hsu CL, Wu MH, Wu CT, et al. 2008. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135: 947-55 955.e1-5.
67. Farza H, Salmon AM, Hadchouel M, Moreau JL, et al. 1987. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci USA 84: 1187-91.
68. Breidbart S, Burk RD, Saenger P. 1993. Hormonal regulation of hepatitis B virus gene expression: influence of androgen receptor. Pediatr Res 34: 300-2.
69. Naugler WE, Sakurai T, Kim S, Maeda S, et al. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-4.
70. Burguete-Garcia AI, Conde-Gonzalez CJ, Jimenez-Mendez R, Juarez-Diaz Y, et al. 2011. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Salud Publica Mex 53: S7-12.
71. Balogun MA, Vyse AJ, Hesketh LM, Kafatos G, et al. 2009. Estimating hepatitis C infection acquired in England, 1986-2000 Epidemiol Infect 137: 1249-54.
72. Grebely J, Raffa JD, Lai C, Krajden M, et al. 2007. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 21: 447-51.
73. Iversen J, Wand H, Gonnermann A, Maher L. 2010. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008 Int J Drug Policy 21: 471-6.
74. Rodriguez-Torres M, Rios-Bedoya CF, Rodriguez-Orengo J, Fernandez-Carbia A, et al. 2006. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol 40: 358-66.
75. Di Martino V, Lebray P, Myers RP, Pannier E, et al. 2004. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 40: 1426-33.
76. Cussigh A, Falleti E, Fabris C, Bitetto D, et al. 2011. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics 63: 33-41.
77. Schott E, Witt H, Hinrichsen H, Neumann K, et al. 2007. Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection. J Hepatol 46: 372-80.
78. Fang JW, Lai CL, Chung HT, Wu PC, et al. 1994. Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr 40: 104-7.
79. Hess G, Hingst V, Cseke J, Bock HL, et al. 1992. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis 11: 334-40.
80. Bock HL, Kruppenbacher J, Sanger R, Hobel W, et al. 1996. Immunogenicity of a recombinant hepatitis B vaccine in adults. Arch Intern Med 156: 2226-31.
81. Zeeshan M, Jabeen K, Ali AN, Ali AW, et al. 2007. Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect Dis 7: 120.
82. Bhattacharya D, Umbleja T, Carrat F, Chung RT, et al. 2010. Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis. J Acquir Immune Defic Syndr 55: 170-5.
83. Narciso-Schiavon JL, Schiavon LdeL, Carvalho-Filho RJ, Sampaio JP, et al. 2010. Gender influence on treatment of chronic hepatitis C genotype 1. Rev Soc Bras Med Trop 43: 217-23.
84. Yu JW, Sun LJ, Zhao YH, Kang P, et al. 2011. Impact of sex on virologic response rates in genotype 1 chronic hepatitis C patients with peginterferon alpha-2a and ribavirin treatment. Int J Infect Dis 15: e740-6.
85. Villa E, Karampatou A, Camma C, Di Leo A, et al. 2011. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology 140: 818-29.
86. Klein SL, Pekosz A, Passaretti C, Anker M, et al. 2010. Sex, Gender and Influenza. Geneva: World Health Organization. p. 1-58.
87. Klein SL, Passaretti C, Anker M, Olukoya P, et al. 2010. The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ 1: 5.
88. Randolph AG, Vaughn F, Sullivan R, Rubinson L, et al. 2011. Critically ill children during the 2009-2010 in fluenza pandemic in the United States. Pediatrics 128: e1450-8.
89. Zarychanski R, Stuart TL, Kumar A, Doucette S, et al. 2010. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 182: 257-64.
90. Tam A, Morrish D, Wadsworth S, Dorscheid D, et al. 2011. The role of female hormones on lung function in chronic lung diseases. BMC Womens Health 11: 24.
91. de Jong MD, Simmons CP, Thanh TT, Hien VM, et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-17.
92. Szretter KJ, Gangappa S, Lu X, Smith C, et al. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 81: 2736-44.
93. Kobasa D, Jones SM, Shinya K, Kash JC, et al. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-23.
94. Merrill RM, Beard JD. 2009. Influenza vaccination in the United States, 2005-2007. Med Sci Monit 15: PH92-100.
95. Endrich MM, Blank PR, Szucs TD. 2009. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine 27: 4018-24.
96. Santibanez TA, Mootrey GT, Euler GL, Janssen AP. 2010. Behavior and beliefs about influenza vaccine among adults aged 50-64 years. Am J Health Behav 34: 77-89.
97. Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, et al. 2010. Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? PLoS ONE 5: e10199.
98. Chor JS, Ngai KL, Goggins WB, Wong MC, et al. 2009. Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. Br Med J 339: b3391.
99. Cook IF, Barr I, Hartel G, Pond D, et al. 2006. Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine 24: 2395-402.
100. Lorenzo ME, Hodgson A, Robinson DP, Kaplan JB, et al. 2011. Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice. Vaccine 29: 9246-55.
101. Lu FX, Abel K, Ma Z, Rourke T, et al. 2002. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin Exp Immunol 128: 10-20.
102. Nguyen DC, Masseoud F, Lu X, Scinicariello F, et al. 2011. 17beta-Estradiol restores antibody responses to an influenza vaccine in a postmenopausal mouse model. Vaccine 29: 2515-8.
103. De Clercq E. 2006. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5: 1015-25.
104. Blanchon T, Mentre F, Charlois-Ou C, Dornic Q, et al. 2012. Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter. Clin Microbiol Infect, in press, DOI: 10.1111/j.1469-0691.2011.03751.x.
105. Maltezou HC, Drakoulis N, Siahanidou T, Karalis V, et al. 2011. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1. Pediatr Infect Dis J 31: 527-9.
106. Guha-Sapir D, Schimmer B. 2005. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2: 1.
107. Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. 2009. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 137: 824-33.
108. Klein SL, Marks MA, Li W, Glass GE, et al. 2011. Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in china, 2004-2008. Clin Infect Dis 52: 1414-21.
109. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, et al. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337: 1105-11.
110. Eshima N, Iwata O, Iwata S, Tabata M, et al. 2009. Age and gender specific prevalence of HTLV-1. J Clin Virol 45: 135-8.
111. Garenne M. 1994. Sex differences in measles mortality: a world review. Int J Epidemiol 23: 632-42.
112. Jean CM, Honarmand S, Louie JK, Glaser CA. 2007. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 13: 1918-20.
113. Hawkins C, Chalamilla G, Okuma J, Spiegelman D, et al. 2011. Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS 25: 1189-97.
114. Emery J, Pick N, Mills EJ, Cooper CL. 2010. Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients. Patient Prefer Adherence 4: 97-103.
115. Ofotokun I, Chuck SK, Hitti JE. 2007. Antiretroviral pharmacokinetic profile: a review of sex differences. Gend Med 4: 106-19.
116. Andany N, Raboud JM, Walmsley S, Diong C, et al. 2011. Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada. HIV Clin Trials 12: 89-103.
117. Straus SE, Corey L, Burke RL, Savarese B, et al. 1994. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343: 1460-3.
118. Zhang X, Castelli FA, Zhu X, Wu M, et al. 2008. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. Clin Vaccine Immunol 15: 1436-49.
119. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, et al. 2008. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 168: 2405-14.